QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

SION

QT68Sionna Therapeutics, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
37.30
+0.57+1.55%
OverviewShort InterestFilings
SIONQT68Sionna Therapeutics, Inc.·NASDAQ
OverviewShort InterestFilings
37.30+1.55%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-
Insider Own-
Shs Outstand45.15M
Perf Week3.47%
Market Cap1.66BForward P/E-EPS next Y-2.79Insider Trans-4.62%Shs Float-Perf Month-1.01%
Enterprise Value1.60BPEG0.76EPS next Q-0.65Inst Own-Short Float-Perf Quarter5.10%
Income-86069487.00P/S0.00EPS this Y-Inst Trans-Short Ratio-Perf Half Y-13.03%
Sales-P/B5.72EPS next Y-8.15%ROA-28.05%Short Interest-Perf YTD-9.33%
Book/sh6.38P/C-EPS next 5Y-ROE-27.31%52W High48.45 -23.01%Perf Year169.31%
Cash/sh4.78P/FCF-EPS past 3/5Y-ROIC-33.35%52W Low13.81 170.09%Perf 3Y-
Dividend Est.-EV/EBITDA-19.78Sales past 3/5Y-Gross Margin0.00%Volatility4.22% 4.75%Perf 5Y-
Dividend TTM-EV/Sales0.00EPS Y/Y TTM-37.86%Oper. Margin0.00%ATR (14)2.69Perf 10Y-
Dividend Ex-Date-Quick Ratio22.60Sales Y/Y TTM-Profit Margin0.00%RSI (14)48.24Recom3.00
Dividend Gr. 3/5Y-Current Ratio22.60EPS Q/Q3.23%SMA20-1.84%Beta1.08Target Price54.00
Payout0.00%Debt/Eq0.03Sales Q/Q-SMA50-6.54%Rel Volume1.77Prev Close36.73
Employees41LT Debt/Eq0.02EarningsAug 10SMA2000.27%Avg Volume416.66KPrice37.30
IPO DateFeb 07, 2025Option/ShortYes / YesEPS/Sales Surpr.-15.38% -Net Debt/EBITDA0.68Volume736,761Change1.55%
Analyst Ratings
DateActionAnalystRatingTarget
May-20-26DowngradeFreedom BrokerBuy → Hold
May-18-26ReiteratedStifel Nicolaus$44 → $55
Jan-07-26ReiteratedBTIGBuy$58
Jan-05-26ReiteratedRaymond James$45 → $53
Dec-01-25DowngradeRBC CapitalSector Perform → Underperform$22 → $24
Sep-03-25InitiatedRBC CapitalSector Perform$22
Sep-02-25InitiatedRaymond JamesStrong Buy$45
Mar-04-25InitiatedGuggenheimBuy$45
Latest News
Jun-10-26
Jun-10-2601:52PM
Sionna Therapeutics, Inc. (SION) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSeekingAlpha
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
Total Revenue
000
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A110
Gross Profit-1-10
Selling, General and Administrative Excl. Other291310
Research and Development605741
Other Operating Expense-10-1
Operating Income-89-71-50
Interest Expense
000
Unusual Expense
———
Non-Operating Income (Expense)-14-9-3
Net Income Before Taxes-75-62-47
Income Taxes
000
Consolidated Net Income-75-62-47
Net Income From Continuing Operations-75-62-47
Net Income-75-62-47
EPS (Recurring)-1.88-1.40-1.07
EPS (Basic, Before Extraordinaries)-1.88-1.40-1.07
EPS (Diluted)-1.88-1.40-1.07
EBITDA-75-61-47
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio
———
Gross Margin
———
Operating Margin
———
Net Margin
———
Shares Outstanding404444
Market Capitalization1,646——
Operating Lease Expense
———
Insider Trading Volume
$39.17$35.64$32.11$28.59$25.06● Close Price0.00M12.71M25.42M38.13M50.83MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Thompson Peter A.DirectorMay 27 '26Sale44.491014,4932,671,721May 29 12:00 AM
ORBIMED ADVISORS LLCDirectorMay 27 '26Sale44.491014,4932,671,721May 29 12:00 AM
ORBIMED ADVISORS LLCDirectorMay 11 '26Sale46.22184,6398,534,0152,671,822May 11 12:00 AM
Thompson Peter A.DirectorMay 11 '26Sale46.22184,6398,534,0152,671,822May 11 12:00 AM
Thompson Peter A.DirectorMay 08 '26Sale44.5859,7672,664,4132,856,461May 11 12:00 AM
ORBIMED ADVISORS LLCDirectorMay 08 '26Sale44.5859,7672,664,4132,856,461May 11 12:00 AM
Thompson Peter A.DirectorMay 07 '26Sale44.6148,5462,165,6372,916,228May 11 12:00 AM
ORBIMED ADVISORS LLCDirectorMay 07 '26Sale44.6148,5462,165,6372,916,228May 11 12:00 AM
ORBIMED ADVISORS LLCDirectorApr 18 '26Sale44.522,948131,2452,964,774Apr 21 12:00 AM
Thompson Peter A.DirectorApr 18 '26Sale44.522,948131,2452,964,774Apr 21 12:00 AM
ORBIMED ADVISORS LLCDirectorApr 17 '26Sale44.6852,3972,341,0982,967,722Apr 21 12:00 AM
Thompson Peter A.DirectorApr 17 '26Sale44.6852,3972,341,0982,967,722Apr 21 12:00 AM
ORBIMED ADVISORS LLCDirectorApr 16 '26Sale45.34226,90610,287,9183,020,119Apr 16 12:00 AM
Thompson Peter A.DirectorApr 16 '26Sale45.34226,90610,287,9183,020,119Apr 16 12:00 AM
ORBIMED ADVISORS LLCDirectorApr 15 '26Sale44.64235,86310,528,9243,247,025Apr 16 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR